Matches in Nanopublications for { ?s ?p "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NP448079.RATL3IxLJFZcJ_dUxywa-2EGwwXRQi-eGhVuptMS8E_tM130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448079.RATL3IxLJFZcJ_dUxywa-2EGwwXRQi-eGhVuptMS8E_tM130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP293229.RAsvok4_Br4NqbAKf6f3AnhvO8gR01s2u4T_cg-ldCZEQ130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293229.RAsvok4_Br4NqbAKf6f3AnhvO8gR01s2u4T_cg-ldCZEQ130_provenance.
- NP779538.RA7iVsviupxYbHAs7PioVPHHp-QPVaYxO2D-_ZcEsVvDs130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779538.RA7iVsviupxYbHAs7PioVPHHp-QPVaYxO2D-_ZcEsVvDs130_provenance.
- NP845903.RA3TXSRe8mfhWBNkm6mlDmealPovfGXMfDEOWGIPptuWw130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845903.RA3TXSRe8mfhWBNkm6mlDmealPovfGXMfDEOWGIPptuWw130_provenance.
- NP468487.RAClxo87r34Pbttc2mivpr9TabZXSTrxzdwzJ1RAeJyqk130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468487.RAClxo87r34Pbttc2mivpr9TabZXSTrxzdwzJ1RAeJyqk130_provenance.
- NP891415.RAKC7VzWOgB9WU9C3grSoA1oq4DidFebARcLdSnj7WTyw130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891415.RAKC7VzWOgB9WU9C3grSoA1oq4DidFebARcLdSnj7WTyw130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468806.RA-TpQeNyZ7sMf-doVHRv5oZf4vUG32U5lrnKzvFe6h9Y130_provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP812324.RA92Q7nbpwshaHzXB5Sj6Lo0ZgCyyplhaPHG68fJP6Cjs130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812324.RA92Q7nbpwshaHzXB5Sj6Lo0ZgCyyplhaPHG68fJP6Cjs130_provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP932255.RAx8oRsQDuL1Ru09gJqk_wY3NNTJlXo6Wzdlmyij_V2v0130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932255.RAx8oRsQDuL1Ru09gJqk_wY3NNTJlXo6Wzdlmyij_V2v0130_provenance.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.
- NP932254.RATY8X8Se_iJ-z_LgYKYEM6WZ4tC_RQNZ-iMEOIULlLWk130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932254.RATY8X8Se_iJ-z_LgYKYEM6WZ4tC_RQNZ-iMEOIULlLWk130_provenance.
- NP932258.RAWnP5M5-gNqQ4MxlSbVA9lJ4kxC7nzpBiy3YgnKGWgYA130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932258.RAWnP5M5-gNqQ4MxlSbVA9lJ4kxC7nzpBiy3YgnKGWgYA130_provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP468825.RAku1gOp_tbSXcu3j_owl7N1IYLzNbQd70TbBIfCm-zZg130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468825.RAku1gOp_tbSXcu3j_owl7N1IYLzNbQd70TbBIfCm-zZg130_provenance.
- NP812301.RAkAD0vta8vX-kHF78VxuXitMIZaeESv3DPxEMnLNVt9c130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812301.RAkAD0vta8vX-kHF78VxuXitMIZaeESv3DPxEMnLNVt9c130_provenance.
- NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932257.RArEg298FJSc9E6EAWTnxTSgnMFn3t-4HaMu5f-PX0vHg130_provenance.
- NP932259.RApgbmbHQBP70Av9rEOs1asvef3TZwW4Wn3FbX1BY6wbc130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932259.RApgbmbHQBP70Av9rEOs1asvef3TZwW4Wn3FbX1BY6wbc130_provenance.